Monday, May 31, 2021

Venus Remedies Ltd (526953) – Growing @ 52%

Venus Remedies Ltd  (526953)  closes   at 332.80  with  a   Gain of   +2.0%   on    31-May-2021  with formation of  a  Small  Red  Candle    on Daily  Price Chart.

About the Company : Venus Remedies is engaged in Business of Pharmaceutical product manufacturing.

Strength : Financial Indicators are turning Good.

Financials : Venus Remedies Ltd  has posted Net Sales / Revenue   of  340.00 Cr & Net Loss  of -10.00 Cr in FY2020 and expected to post Net Sales / Revenue   of 520.00 Cr & Net Profit of 21.00Cr in FY2021 .

Valuations  : The Company is now Trading at X 2..60  of its  valuations ( last 4Quaters FY2021 earnings considered here) at ~160% premium  and at X1.20  of its FY 2022, which is now almost  ~20%  Premium to its value .

Margin of Safety (1Yr Bond Yield: Value>1 ) is now  -1.30 which  makes is attractive .  The  Equity Value Per Share ( Enterprise Value Method ) is  332.80

If We factor its earnings/valuations, its Price arrives at 738 with consideration FY2022 earnings.

Disclaimer : We are / may going to take exposure shortly.

Join Us at   Telegram #   https://t.me/TheNiftyNext

Data Source NSE Website | Screener.In  | Capital Line Money Control |

The author tracks economic, behavioural and corporate tends, hoping to gauge good avenues of return based on Fundamental Valuations of Stocks, a follower of EPV method. You can reach me/us at | Twitter # NiftyNext1 |  e-Mail : Mail@NiftyNext.Com  |  Tel +91 8802230836  |  Telegram # TheNiftyNext   |

Manage your investments the right way With MProfit. Visit https://www.mprofit.in/

Use Our Referral Link to Get 20% DISCOUNT @ https://www.mprofit.in/buy?referral=R1GD99J496AB1345D


Sunday, May 30, 2021

Barbeque-Nation Hospitality Ltd (543283) – Debt-free at the net level

Barbeque-Nation Hospitality Ltd (543283) closes   at 853.00  with  a   Fall  of   -2.80%   on    28-May-2021  with formation of  a  Small  Red  Candle    on Daily  Price Chart.

About the Company : Incorporated in 2006, Barbeque Nation is one of the leading casual dining chains in India. Barbequ Nation Hospitality Limited (BNHL) is a pioneer in "over the table barbeque" live grills embedded in dining tables

Strength : The recent fund-raising by BNHL (pre- and post-IPO) has strengthened its balance sheet and the company is debt-free at the net level. Timely liquidity infusion will enable the company to survive the second wave and emerge stronger, once the pandemic recedes.

 

Financials : Barbeque-Nation Hospitality Ltd  has posted Net Sales / Revenue   of  507.10 Cr & Net Loss  of -90.50 Cr in FY2021 and expected to post Net Sales / Revenue   of 897.50 Cr & Net Profit of 5.10 Cr in FY2022 & Net Sales / Revenue   of 1095.00 Cr & Net Profit of 5.98Cr in FY2023

Valuations  : The Company is now Trading at X 37.50   of its  valuations of its FY2022 earnings and X5.98 of its FY2023 earnings.

Margin of Safety (1Yr Bond Yield: Value>1 ) is now  -0.70  which  makes is attractive after a ~50% fall in market price. The  Equity Value Per Share ( Enterprise Value Method ) is  784.10

 

If We factor its earnings/valuations, its Price arrives at 1064 with consideration FY2022 earnings.

Disclaimer : We are / may going to take exposure shortly.

Join Us at   Telegram #   https://t.me/TheNiftyNext

Data Source NSE Website | Screener.In  | Capital Line Money Control |

The author tracks economic, behavioural and corporate tends, hoping to gauge good avenues of return based on Fundamental Valuations of Stocks, a follower of EPV method. You can reach me/us at | Twitter # NiftyNext1 |  e-Mail : Mail@NiftyNext.Com  |  Tel +91 8802230836  |  Telegram # TheNiftyNext   |

Manage your investments the right way With MProfit. Visit https://www.mprofit.in/

Use Our Referral Link to Get 20% DISCOUNT @ https://www.mprofit.in/buy?referral=R1GD99J496AB1345D

 


Saturday, May 29, 2021

KMC Speciality Hospitals (India) Ltd (524520) – Benefiting from COVID-19

KMC Speciality Hospitals (India) Ltd (524520) closes   at 39.70 with  a   Fall  of   - 1.40%   on    28-May-2021  with formation of  a  Red  Candle    on Daily  Price Chart.

About the Company : KMC Specialty Hospitals India Limited (KMCL), established in 1982, is a part of the Kauvery Group of Hospitals based at Tiruchirappalli (Trichy). The company runs Kauvery Hospital, a 220 bed super specialty hospital that offers services in neurology, obstetrics & gynecology, pediatrics, cardiology, ENT, dental, joint replacement among others. Further, during FY2018, the company also started lever transplantation services in the hospital. Kauvery group of hospitals is one of the reputed hospital chain with about 1200 beds across Tamil Nadu. KMC is a publicly listed company with Bombay Stock Exchange

Sector Update : Positive

Strength :  1. Experienced management and establish presence

2.. Comfortable financial risk profile

Weaknesses : 1. Moderate scale within the industry, geographical concentration risk and intense competition ( KMC operates only one hospital with 220 beds; the same are modest within the industry dominated by large players like Apollo Hospitals, CARE Hospitals among others. Further, KMC’s entire revenues are skewed from a single location property. Any unforeseen eventuality will impact the entire business and financial risk profile of the company. Though KMC has a brand ‘Kauvery’ in the State of Tamil Nadu with a chain of hospitals with aggregate bed capacity of about 1200, however KMC Hospital at Trichy remain under pressure and faces competition from other leading hospitals in the vicinity as reflected in volatile operating margins )

2. Project execution risk (The company has proposed a new project to setup a Mother and Child Health Care hospital which is under construction. However it was delayed due to Covid for a period of 6 months due to lockdown and now it is expected to be completed by April 2023. The cost of the project is around Rs. 75 to 80 crores of which Rs.50 - 60 crores will be provided by the bank and the balance Rs. 25.00 crores will be funded through internal accruals and promoters )

Financials : KMC Speciality Hospitals (India) Ltd  has posted Net Sales / Revenue   of 103.00 Cr & Net Profit of 13.00 Cr in FY2021 .

Valuations  : The Company is now Trading at X 3.0  of its  valuations ( FY2021 earnings considered here) with ~200 % premium ( While Apollo Hospitals Enterprise Ltd is Trading X6.0 of its Valuations )

Margin of Safety (1Yr Bond Yield: Value>1 ) is now  0.50  which  makes is attractive after a ~50% fall in market price. The  Equity Value Per Share ( Enterprise Value Method ) is  39.70

Whats  best in It   :It has passed on the indicator Growth Candidate ( If >1 ), which is now 1.1 and Future Stocks Price  Upmove Start Index ( FSPUI ) Decline after Up which is a good Indicators for a Multibagger.

If We factor its earnings/valuations, its Price arrives at 54.20 with consideration FY2022 earnings (Historical 10Yrs Growth Rate basis ).

Disclaimer : We are / may going to take exposure shortly.

Join Us at   Telegram #   https://t.me/TheNiftyNext

Data Source NSE Website | Screener.In  | Capital Line Money Control |

The author tracks economic, behavioural and corporate tends, hoping to gauge good avenues of return based on Fundamental Valuations of Stocks, a follower of EPV method. You can reach me/us at | Twitter # NiftyNext1 |  e-Mail : Mail@NiftyNext.Com  |  Tel +91 8802230836  |  Telegram # TheNiftyNext   |

 

Manage your investments the right way With MProfit. Visit https://www.mprofit.in/

Use Our Referral Link to Get 20% DISCOUNT @ https://www.mprofit.in/buy?referral=R1GD99J496AB1345D

 

 


Disclaimer

The recommendations made herein do not constitute an offer to sell or a solicitation to buy any of the securities mentioned. No representations can be made that the recommendations contained herein will be profitable or that they will not result in losses. Readers using the information contained herein are solely responsible for their actions. Information is obtained from sources deemed to be reliable but is not guaranteed as to accuracy and completeness. The above recommendations are based on the theory of Technical Analysis and do not reflect the fundamental validity of the Scrip. www.niftynext..com does 't take any Responsibility for any losses arising from using the Stocks Recommendations.
We( WWW.NIFTYNEXT.COM) are not Registered with Any Regulatory Body in India ie SEBI,NSE,BSE,AMFI or Any Otheres.


Blog Archive